Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2024

Dec 9, 2024

31708_dirs_2024-12-09_32ed31cd-b232-4fc9-ac54-53b841b2987f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2024-12-05

Reporting Person: Ross Bridget A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-05 Dividend Equivalent Rights $ A 0.3103 Acquired Common Stock (0.3103) Direct
2024-12-05 Dividend Equivalent Rights $ A 0.6284 Acquired Common Stock (0.6284) Direct
2024-12-05 Dividend Equivalent Rights $ A 0.6284 Acquired Common Stock (0.6284) Direct
2024-12-05 Dividend Equivalent Rights $ A 0.80430 Acquired Common Stock (0.80430) Direct

Footnotes

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.